In this webinar Reorg’s team discussed the latest events surrounding Bausch Health. We walked through a variety of topics, including the Bausch + Lomb spinoff, Xifaxan (patent trial and competition), the company’s options in light of covenant limitations, and more.
Weekly highlights from our global intel and expert analysis